Existing drugs and their application in drug discovery targeting cancer stem cells

Area of Science:

• Oncology
• Pharmacology
• Cancer Biology

Background:

• Standard cancer therapies often fail due to tumor relapse and metastasis.
• Cancer stem cells (CSCs) are a subpopulation responsible for tumor recurrence, drug resistance, and metastasis.
• Targeting CSCs is crucial for effective and durable cancer treatment.

Purpose of the Study:

• To review recent advancements in drug repositioning for targeting cancer stem cells (CSCs).
• To discuss the potential of repurposed drugs in overcoming CSC-mediated cancer relapse and metastasis.
• To highlight CSCs as a promising therapeutic target for novel cancer treatments.

Main Methods:

• Literature review of drug repositioning studies targeting CSCs.
• Analysis of in vitro and in vivo models for CSC drug screening.
• Evaluation of existing drugs for new anti-CSC indications.

Main Results:

• Identification of several existing drugs with potential anti-CSC activity.
• Demonstration of drug repositioning as a viable strategy for CSC-targeted cancer therapy.
• Highlighting the potential for faster drug development due to favorable safety profiles of repurposed drugs.

Conclusions:

• Drug repositioning offers a promising avenue for developing novel therapeutics against cancer stem cells.
• Repurposed drugs may provide safer and more rapidly deployable treatment options for overcoming cancer relapse and metastasis.
• Targeting CSCs through drug repositioning holds significant potential for improving patient outcomes in oncology.